Article Per Year (5 Year)
p-Index From 2021 - 2026
1.048
P-Index
This Author published in this journals
All Journal Indonesian Journal of Rheumatology
Rudy Hidayat
Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
Medicine & Pharmacology

Published : 13 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 13 Documents
Search

 1   2 
Indonesian Rheumatologist Association (IRA) Recommendations for Diagnosis and Management of Peripheral Spondyloarthritis 2021 Sumartini Dewi; Arief Nurudhin; Ayu Paramaiswari; R.M. Suryo Anggoro Kusumo Wibowo; Yulyani Werdiningsih; Surya Darma; Lita Diah Rahmawati; Rudy Hidayat; Sumariyono
Indonesian Journal of Rheumatology Vol. 13 No. 1 (2021): Indonesian Journal of Rheumatology
Publisher : Indonesian Rheumatology Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/ijr.v13i1.175

Abstract

Objective. Spondyloarthritis recommendations are made to provide guidance in diagnosis, treatment, and monitoring of peripheral spondyloarthritis cases.Method. Literature searches were conducted online. The drafting team determines the levels of evidence (LOE) and grades of recommendation (GOR). After conducting a discussion, each recommendation that has been agreed upon by the drafting team is then classified based on the levels of evidence and grades of recommendation. The final step in the preparation of these recommendations is to determine the level of agreement (LOA) on each recommendation carried out by a team of panelists who have been appointed by IRA.Result. Thirty five recommendations regarding peripheral spondyloarthritis were compiled. There are 6 strong recommendation or GOR A for psoriatic arthritis and 8 recommendations for enteropathic arthritis.Conclusion. These recommendations provide directions for clinicians to diagnose and to manage peripheral spondyloarthritis.
The Prevalence and Factors Associated with Metabolic Syndrome in Rheumatoid Arthritis Patients Rudy Hidayat; Ricky; Dicky L. Tahapary; Hamzah Shatri; RM. Suryo Anggoro; Anna Ariane; Sumariyono
Indonesian Journal of Rheumatology Vol. 14 No. 2 (2022): Indonesian Journal of Rheumatology
Publisher : Indonesian Rheumatology Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/ijr.v14i2.206

Abstract

Background: Rheumatoid arthritis (RA) is an independent risk factor of cardiovascular disease (CVD), causing 30-50% mortality in RA patients. Metabolic syndrome is a combination of metabolic disorders that can be manifested as central obesity, impaired blood pressure, or abnormalities of carbohydrate and lipid metabolism, which is closely associated with CVD in RA patients. The prevalence and factors associated with the incidence of metabolic syndrome in RA patients vary in previous studies. This study aimed to determine the prevalence and factors associated with the incidence of metabolic syndrome in RA patients at Cipto Mangunkusumo National Central General Hospital, Jakarta. Methods: A total of 145 RA patients at the Rheumatology Clinic of Cipto Mangunkusumo National Central General Hospital from October to December 2021 were included as research subjects by consecutive sampling method. History taking about the disease and demographic data, physical and anthropometric examination, and laboratory tests were done on the patients. The prevalence of the metabolic syndrome was determined using harmonization criteria. Statistical analysis was performed to determine the association of the variables of age, smoking habit, disease activity, duration of disease, glucocorticoid treatment, and methotrexate treatment with metabolic syndrome in RA patients. Results: The prevalence of metabolic syndrome was 19.3% in RA patients with a mean age of 49.8 ± 11.6 years. The variables of gender, age, deformity, physical activity, extraarticular manifestation, smoking habit, disease activity, disease duration, glucocorticoid treatment, and methotrexate treatment were not statistically significant to the incidence of metabolic syndrome in RA patients. Conclusion: The prevalence of metabolic syndrome in RA patients in this study was 19.3%, and no variable was associated with the prevalence of metabolic syndrome.
Indonesian Rheumatology Association (IRA) Recommendations for Diagnosis and Management of Glucocorticoid-induced Osteoporosis Bagus Putu Putra Suryana; Rudy Hidayat; Laniyati Hamijoyo; Radiyati Umi Partan; Yulyani Werdiningsih; Surya Darma; RM Suryo Anggoro; Anna Ariane; Faisal Parlindungan; Mirza Zaka Pratama; Harry Isbagio; Handono Halim; Cesarius Singgih Wahono; Sumariyono
Indonesian Journal of Rheumatology Vol. 14 No. 2 (2022): Indonesian Journal of Rheumatology
Publisher : Indonesian Rheumatology Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/ijr.v14i2.216

Abstract

Background: Patients receiving long-term glucocorticoid therapy are at risk of developing GIOP. However, until today, there is still no guideline that specifically explains how to diagnose and manage GIOP patients in Indonesia. Methods: 10 selected rheumatologists from the Indonesian Rheumatologist Association (IRA) made recommendations based on key questions formed by a steering committee from IRA. These recommendation materials were taken from several online databases such as Pubmed, Science Direct, and Cochrane. Level of evidence and grades of recommendation were then assigned, and every member of the panelist team will assign a score for the level of agreement. Results: A total of 17 recommendations regarding screening, prevention, diagnosis, therapy, and monitoring for GIOP were made. Conclusion: These recommendations can be used for adult patients receiving long-term glucocorticoids with or at risk of developing GIOP. The prevention measure, diagnostic, therapy, and monitoring algorithm in this recommendation are all created with the consideration of Indonesia’s clinical setting, facility, and drug availability.
Co-Authors Achmad Fauzi Anindito, Bagus Anna Ariane Anna Ariane Anna Ariane Anna Ariane Anna Ariane Arief Nurudhin Awalia Awalia Ayu Paramaiswari Ayu Paramaiswari Bambang Setiyohadi Dicky L. Tahapary Dicky Levenus Tahapary Dwi Budi Darmawati Endy Adnan Esthika Dewiasty, Esthika Faisal Parlindungan Faisal Parlindungan Faisal Parlindungan Gede Kambayana Ginting, Andi Raga Hamzah Shatri Handono Halim Harry Isbagio Harry Isbagio Harry Isbagjo Herlina Yani I Nyoman Suarjana Ika Prasetya Wijaya Ika Vemilia Ikhwan Rinaldi Jerry Eddya Putra Boer Kasjmir, Yoga I Laniyati Hamijoyo, Laniyati Linda Kurniaty Wijaya Lisa Kurnia Sari Marcel Prasetyo Marcellus Simadibrata Muhadi Muhadi Pande Ketut Kurniari Perdana Aditya Pratama, Mirza Zaka Pringgodigdo Nugroho, Pringgodigdo R.M. Suryo Anggoro Kusumo Wibowo Radiyati Umi Partan Rakhma Yanti Hellmi Rakhma Yanti Hellmi Ratih Manuaba Reza Yogaswara Ricky Ridho Adriansyah RM Suryo Anggoro RM. Suryo Anggoro RM. Suryo Anggoro KW Safri, Ahmad Yanuar Santosa, David Sosialita, Tiara Diah Sukamto Koesnoe Sukamto Koesnoe Sumariyono Sumariyono Sumariyono Sumariyono Sumariyono Sumariyono Sarmidi Sumartini Dewi Sumartini Dewi Surya Darma Surya Darma Suryana, Bagus Putu Putra Utari, A P Wahono, Cesarius Singgih Yulyani Werdiningsih Yulyani Werdiningsih